Patient Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Resistance
New drug resistance study results reported from University of Sherbrooke
January 7th, 2007
Investigators publish new data in the report "Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Receipt of fluoroquinolones was the predominant risk factor for Clostridium difficile-associated disease (CDAD) during an epidemic in Quebec, Canada. To determine the role of antimicrobial drugs in facilitating healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) colonization and infection and to compare this role with their effects on methicillin-susceptible S. aureus infection and CDAD, we conducted a retrospective cohort study of patients in a Quebec hospital," scientists writing in the journal Emerging Infectious...
Source: Patient Care Law Weekly (2007-01-07)
|
|
Advertisement |
|
|
|
